A citation-based method for searching scientific literature

Renata Rodrigues da Cunha Colombo Bonadio, Rodrigo Nogueira Fogace, Vanessa Costa Miranda, Maria Del Pilar Estevez Diz. Clinics (Sao Paulo) 2018
Times Cited: 29

. Nature 2011
Times Cited: 4670

List of shared articles

Times cited

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression.
Stephanie Lheureux, Ana Oaknin, Swati Garg, Jeffrey P Bruce, Ainhoa Madariaga, Neesha C Dhani, Valerie Bowering, Justin White, Sarah Accardi, Qian Tan,[...]. Clin Cancer Res 2020

Prevalence of Tissue BRCA Gene Mutation in Ovarian, Fallopian Tube, and Primary Peritoneal Cancers: A Multi-Institutional Study.
Arb-Aroon Lertkhachonsuk, Prapaporn Suprasert, Tarinee Manchana, Thannaporn Kittisiam, Nuttavut Kantathavorn, Tharintorn Chansoon, Surapan Khunamornpong, Natkrita Pohthipornthawat, Siriwan Tangjitgamol, Taksa Luasiripanthu,[...]. Asian Pac J Cancer Prev 2020

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.
Cécile Le Page, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher, Anne-Marie Mes-Masson. Curr Drug Targets 2020

Educational Case: High-Grade Serous Carcinoma of the Ovary.
Sophia Bunde, Swikrity Upadhyay Baskota, Jeffrey Fine, Samer Khader. Acad Pathol 2021

Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.
Edward Grimley, Alexander J Cole, Thong T Luong, Stacy C McGonigal, Sarah Sinno, Dongli Yang, Kara A Bernstein, Ronald J Buckanovich. Theranostics 2021